Clinical Trials Logo

Intestinal Pseudo-Obstruction clinical trials

View clinical trials related to Intestinal Pseudo-Obstruction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05654649 Recruiting - Postoperative Ileus Clinical Trials

Dexamethasone in the Prevention of Post-spinal Paralytic Ileus After Cesarean Section

Start date: December 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Postoperative ileus is a perplexing problem for clinical surgeons. It occurs not only after abdominal surgery but also after any surgery that requires general anesthesia. Postoperative ileus is defined as the dysfunction of gastrointestinal motility after surgery, characterized by a decrease in, or stagnation of, intestinal peristalsis.

NCT ID: NCT04506593 Recruiting - Constipation Clinical Trials

Indiana University Gastrointestinal Motility Diagnosis Registry

Start date: November 2014
Phase:
Study type: Observational [Patient Registry]

Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to identify the patients with specific disease conditions. It will also help in promoting future research in gastroenterology motility disorders

NCT ID: NCT04193735 Recruiting - Clinical trials for Chronic Intestinal Pseudo-Obstruction

Pseudo-obstruction Assessment With MRI

POM
Start date: January 17, 2020
Phase:
Study type: Observational

This study will explore the potential for a standardized MRI scan after a liquid meal to be used in diagnosis of the rare but debilitating chronic intestinal pseudo-obstruction (CIPO).

NCT ID: NCT04190173 Recruiting - Critically Ill Clinical Trials

Efficacy of PRUcalopride in Critically Ill Patients With Paralytic ILeus

EPRUCIL
Start date: July 1, 2017
Phase: Phase 3
Study type: Interventional

Paralytic ileus is a common intestinal dysfunction in critically ill patients. There are still no established the effective medications except correcting the primary causes and prokinetics trial which limited in efficacy and potential adverse events.

NCT ID: NCT03041675 Recruiting - Paralytic Ileus Clinical Trials

Effects of Laser Acupuncture Therapy on Paralytic Ileus

Start date: February 13, 2017
Phase: N/A
Study type: Interventional

Ileus occurs from hypomotility of the gastrointestinal tract. Causes of Paralytic ileus include post-operation, stroke, and bed-ridden for a long time. Medicine treatment is less and less effective over time. Some study revealed that Moxibustion and Acupuncture are effective in Paralytic ileus. Investigators try to find other treatment except of medicine. Laser Acupuncture is a safe and non-invasive choice. This study is to evaluate effect of Laser Acupuncture on Paralytic ileus.

NCT ID: NCT01793168 Recruiting - Clinical trials for Retinitis Pigmentosa

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS
Start date: July 2010
Phase:
Study type: Observational [Patient Registry]

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access. Visit sanfordresearch.org/CoRDS to enroll.

NCT ID: NCT01694953 Recruiting - Clinical trials for Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)

The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)

NAHIM
Start date: February 2013
Phase:
Study type: Observational

This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in future clinical trials. Additional clinical centers will be listed as they become available.